SSTR2 and neoplasm: In IHC analysis, the B-cell non-Hodgkin lymphoma was the only tumor to demonstrate a positivity for SSTR2 presence (20%) with an intensity of SSTR2 (grade of 2), which explains its weak tracer uptake in DOTATOC PET/CT.